NMDA Pathology and Treatment of Schizophrenia

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|32|5118-5126

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.32, 2014-10, pp. : 5118-5126

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neurochemistry of Schizophrenia: The Contribution of Neuroimaging Postmortem Pathology and Neurochemistry in Schizophrenia

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 21, 2012-11 ,pp. : 2375-2392

Bentham Science Publishers

Access to resources Recommend Favorite

Influence of combined treatment with NMDA and non-NMDA receptor antagonists on electroconvulsions in mice

By Czuczwar S.J.   Borowicz K.K.   Kleinrok Z.   Tutka P.   Zarnowski T.   Turski W.A.  

European Journal of Pharmacology, Vol. 281, Iss. 3, 1995-08 ,pp. : 327-333

Elsevier

Access to resources Recommend Favorite

Membrane Pathology in Schizophrenia: Implication for Arachidonic Acid Signaling

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 3, Iss. 1, 2003-03 ,pp. : 57-65

Bentham Science Publishers

Access to resources Recommend Favorite

Progress Towards Validating the NMDA Receptor Hypofunction Hypothesis of Schizophrenia

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 8, 2006-04 ,pp. : 771-785

Bentham Science Publishers

Access to resources Recommend Favorite

Meta-Analysis of the Efficacy of Adjunctive NMDA Receptor Modulators in Chronic Schizophrenia

By Singh Surendra P.   Singh Vidhi  

CNS Drugs, Vol. 25, Iss. 10, 2011-10 ,pp. : 859-885

Adis International

Access to resources Recommend Favorite